167 related articles for article (PubMed ID: 7178876)
1. [Particularly severe calcium metabolic disorder in nephropathy from analgesic abuse].
Jaeger P; Burckhardt P; Wauters JP; Trechsel U; Bonjour JP
Schweiz Med Wochenschr; 1982 Dec; 112(49):1791-4. PubMed ID: 7178876
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a particularly severe secondary hyperparathyroidism in analgesic abuse nephropathy.
Jaeger P; Burckhardt P; Wauters JP; Trechsel U; Bonjour JP
Am J Nephrol; 1985; 5(5):342-50. PubMed ID: 4061503
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
5. Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy.
Gonwa TA; Hamilton RW; Buckalew VM
Arch Intern Med; 1981 Mar; 141(4):462-5. PubMed ID: 7212889
[TBL] [Abstract][Full Text] [Related]
6. Regulation of parathyroid hormone and vitamin D in essential hypertension.
Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
[TBL] [Abstract][Full Text] [Related]
7. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
9. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of renal failure progression two years prior to dialysis.
Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
[TBL] [Abstract][Full Text] [Related]
11. Ionised and total serum magnesium in renal transplant patients.
Mazzaferro S; Barberi S; Scarda A; Pasquali M; Rubino F; D'Erasmo E
J Nephrol; 2002; 15(3):275-80. PubMed ID: 12113599
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
13. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R
Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
[TBL] [Abstract][Full Text] [Related]
14. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
15. Analgesic nephropathy: an important cause of chronic renal failure.
Cove-Smith JR; Knapp MS
Q J Med; 1978 Jan; 47(185):49-69. PubMed ID: 674550
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
[TBL] [Abstract][Full Text] [Related]
17. [Phenacetin abuse II. Chronic renal insufficiency in Basle autopsies].
Mihatsch MJ; Schmidlin P; Brunner FP; Hofer HO; Six P; Zollinger HU
Schweiz Med Wochenschr; 1980 Jan; 110(4):116-24. PubMed ID: 6987731
[TBL] [Abstract][Full Text] [Related]
18. Calcium and vitamin D homeostasis in patients with heavy proteinuria.
Saha H
Clin Nephrol; 1994 May; 41(5):290-6. PubMed ID: 8050209
[TBL] [Abstract][Full Text] [Related]
19. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid function after successful renal transplantation.
Botha JF; Botha JR
S Afr J Surg; 1997 Aug; 35(3):113-6. PubMed ID: 9429326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
